By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dutch array-based diagnostics firm Skyline Diagnostics today announced a deal with Janssen Pharmaceutica for the analysis of an undisclosed marketed compound.

Under the terms of the deal, Skyline will use its expertise and technologies in genetic profiling and bioinformatics to generate and analyze diagnostics information related to the compound from Janssen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.